Alsieni, M., Babader, R., Kenany, S., Abdulgader, S., Alafif, R., Alahmadi, A., Aloufi, A., Fallatah, E., AlQahtani, R., & Izaldin, A. (2024). The prevalence Regarding the Use of Glucagon-like Peptide-1 (GLP-1) Agonists as an Obesity Treatment among Adult Patients at King Abdulaziz University Medical Services Center, Jeddah, Saudi Arabia: a Descriptive Cross-Sectional Study: The prevalence of Glucagon-like Peptide-1 (GLP-1) Agonists use as an Obesity Treatment among adults in Saudi Arabia. Journal of King Abdulaziz University: Medical Sciences, 31(2). Retrieved from https://journals.kau.edu.sa/index.php/MedSci/article/view/2412